Moat Ross
Reporting owner on Forms 3, 4 and 5, CIK 1857177.
Moat Ross reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-03.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430 | officer (CHIEF OPERATING OFFICER) | 1 | 2026-11-03 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +9,412 | $18.06 | 19,706 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +12,302 | $21.77 | 32,008 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +6,263 | $22.89 | 38,271 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -6,681 | $91.23 | 31,590 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -8,932 | $92.05 | 22,658 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -11,642 | $93.15 | 11,016 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -722 | $94.05 | 10,294 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -9,412 | $0 | 15,793 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -12,302 | $0 | 27,062 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -6,263 | $0 | 1,691 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +16,111 | $10.76 | 32,418 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +21,059 | $11.1 | 53,477 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +3,760 | $11.97 | 57,237 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +1,658 | $12.97 | 58,895 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +16,112 | $17.76 | 75,007 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +10,895 | $18.06 | 85,902 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -37,775 | $92 | 48,127 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -15,114 | $92.81 | 33,013 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -8,430 | $93.97 | 24,583 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -6,282 | $94.92 | 18,301 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -3,672 | $96.03 | 14,629 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -1,760 | $97.1 | 12,869 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -2,575 | $97.76 | 10,294 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -16,111 | $0 | 7,250 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -21,059 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -3,760 | $0 | 23,492 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -1,658 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -16,112 | $0 | 11,277 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -10,895 | $0 | 25,205 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001857177-26-000010 | Kiniksa Pharmaceuticals International, plc | 2026-11-03 |